loader2
Partner With Us NRI

Apollo Hospitals Enterprise Ltd share Price Today

Company details

6,403.00
6,464.00
4,726.00
6,874.45
6M Return 11.25%
1Y Return 25.11%
Mkt Cap.(Cr) 92,794.53
Volume 298,376
Div Yield 0.09%
OI
-
OI Chg %
-
Volume 298,376
NSE

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Apollo Hospitals Enterprise announced Q3FY24 & 9MFY24 results:

Consolidated Q3FY24:

  • Revenues at Rs 48,506 million vs Rs 42,636 million in Q3FY23; growth of 14% YoY
  • EBITDA at Rs 6,137 million vs Rs 5,053 million in Q3FY23. This is after Apollo 247 cost of Rs 1,557 million in the quarter (including Rs 141 million non-cash ESOP charge) vs Rs 2,024 million in Q3 FY23.
  • Reported PAT at Rs 2,453 million vs Rs 1,535 million in Q3FY23
  • Diluted EPS of Rs 17.06 per share in Q3FY24 (not annualized)

Consolidated 9MFY24:

  • Revenue at Rs 141,153 million vs Rs123,103 million in 9MFY24; growth of 15% YoY
  • EBITDA at Rs 17,502 million vs Rs 15,615 million in 9MFY23. This is after Apollo 247 cost of Rs 5,569 million for 9M(including Rs 785 million non-cash ESOP charge) vs Rs 5,181 million in 9MFY23.
  • PAT stood at Rs 6,448 million vs Rs 5,315 million in 9MFY23
  • Reported PAT stood at Rs 6,448 million vs Rs 6,746 million in 9MFY23
  • Diluted EPS of Rs 44.84 per share in 9MFY24

Health Care service Q3FY24 Performance:

  • Revenue at Rs 24,635 million vs Rs 21,944 million in Q3 FY23; growth of 12% YoY
  • EBITDA grew by 8% at Rs 5,860 million vs Rs 5,428 million in Q3FY23; Margins at 23.8% in Q3FY24
  • PAT stood at Rs 2,872 million vs Rs 2,609 million in Q3FY23, 10% growth

Health Care service 9MFY24 Performance:

  • Revenue at Rs 73,044 million vs Rs 64,823 million in 9MFY23; growth of 13% YoY
  • EBITDA grew by 10% at Rs 17,627 million vs Rs 15,984 million in 9MFY23; Margins at 24.1% in 9MFY24
  • PAT stood at Rs 8,648 million vs Rs 9,043 million in 9MFY23

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, "In the pursuit of a healthier nation, Apollo remains steadfast in its belief in the importance of preventive healthcare. Our mission is to empower individuals to safeguard their well-being, preventing the onset of NonCommunicable Diseases (NCDs). In a country where 5.8 million lives are claimed annually by NCDs, and 1 in 4 Indians faces the risk of such an outcome before the age of 70, Apollo ProHealth emerges as a beacon of comprehensive personalized prevention. Combining medical expertise with Artificial Intelligence, this program, curated by skilled physicians, evaluates overall health, predicts risks, and guides individuals on a personalized path to wellness. It equips you with the tools and knowledge to make proactive choices for your well-being.

Our vision is resolute – to integrate preventive healthcare into the lives of every Indian. More than a business objective, it's a commitment to our nation's health. Together, let's strive to nurture countless healthy and happy families, shielding them from the growing threat of noncommunicable diseases.”

Result PDF

View Other Company Results

Apollo Hospitals Enterprise Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (2)

  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (1)

  • High PE (PE > 40)
Discover More

Resistance and support

R1 6,477.5
R2 6,501.2
R3 6,538.5
Pivot

6,440.23

S1 6,416.5
S2 6,379.2
S3 6,355.5
EMA SMA
6,273.8
6,175.8
6,097.5
5,863.8
6,261.1
6,072.9
6,170.3
5,870.5
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
AIA VCC - AIA ASIAN EQUITY FUND Block Purchase 2023-11-16 5311.25 22091 BSE
AIA INTERNATIONAL LIMITED Block Sell 2023-11-16 5311.25 22091 BSE
AIA VCC - AIA ASIAN EQUITY FUND Block Purchase 2023-10-19 5009.95 42216 BSE
Discover More
Name Category Shares
Ms. Suneeta Reddy PROMOTER 3.36%
Ms. Sangita Reddy PROMOTER 1.69%
Ms. Shobana Kamineni PROMOTER 1.56%
Mr. K Vishweshwar Reddy PROMOTER 1.1%
Ms. Preetha Reddy PROMOTER 0.73%
M/s. PCR Investments Ltd PROMOTER 18.93%

OUR RESEARCH VIEW

Investment recommendation
Good set of numbers with margin expansion …
Call Date
04 Jun 2024
Entry Price 5,865.00
Target Price 6,530.00
Duration
12 Month
HOLD View Report
DISCOVER MORE

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Apollo Hospitals Enterprise Ltd Stocks COMPARISON

Financials( ₹ in Cr) Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Global Health Ltd Narayana Hrudayalaya Ltd
Price 6,453.70 921.00 488.90 1,208.30 1,244.15
% Change 1.22 1.48 4 -3.52 1.55
Mcap ₹ Cr 92,794.53 89,513.10 36,909.90 32,443.70 25,425.57
Revenue TTM ₹ Cr 16,612.50 4,831.37 7,175.67 2,280.01 4,524.77
Net Profit TTM ₹ Cr 887.50 1,103.51 645.22 360.89 606.57
PE TTM 103.43 84.60 63.18 67.87 32.20
1 Year Return 25.11 50.33 51.53 74.19 22.25
ROCE 14.16 13.85 9.65 17.19 29.27
ROE 15.04 16.12 7.81 13.52 33.51
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 6,197.40 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 101,404.97 51,097.20
LAST 6M 186,293.66 40,305.54
LAST 12M 309,547.75 87,515.42
Apollo Hospitals Enterprise Limited - Loss of Share Certificates

Jul 15, 2024 l NSE Announcement

Apollo Hospitals Enterprise Limited - Loss of Share Certificates

Jul 12, 2024 l NSE Announcement

DISCOVER MORE
Date Action Type Ratio
Aug 16, 2024 Dividend 200
Feb 20, 2024 Dividend 120
Aug 18, 2023 Dividend 180
DISCOVER MORE

Apollo Hospitals Enterprise Ltd Information

Stock PE (TTM)
103.43
Promoter Holding
29.33%
Book Value
481.8033
ROCE
14.16%
ROE
15.04%
Description

  • Apollo Hospitals Enterprise Ltd works in the Healthcare sector is having a market capitalization worth Rs. 68,247.55 crores, it was incorporated in the year 1983. It has reported consolidated sales of Rs. 2,867.95 crores in March’2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 508869, and also listed on the National Stock Exchange (NSE) with the code APOLLOHOSP.

    Apollo Hospitals Enterprise Ltd is an Indian international hospital chain having its headquarters in Chennai, Tamil Nadu. Many of the Apollo Hospitals' hospitals have been among the country's first to receive an international healthcare certification from the Joint Commission International (JCI) and the National Accreditation Board for Hospitals and Healthcare Service Providers. Apart from the Hospital business, Apollo has established a presence in Pharmacies, Primary Care, and Diagnostics. Apollo hospitals has a national presence through an established network of over 70 hospitals and 3800 pharmacies spread across the country. The promoters of the company own 29.82% of the stake in the company, Foreign Institutional Investors (FII) own 53.23%, Domestic Institutional Investors (DII) own 11.08% stake in the company, and others (such as public & retail investors) hold the balance of 5.87%.

    In June 2021, quarterly net revenue was Rs. 2,994.71 crores, which has increased sharply by approximately 52.67 % from Rs. 1,961.52 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 150.04 crores, which has improved sharply and increased by nearly 200.62% from a net loss of Rs. 149.11 crores in June 2020. In June 2021, the reported operating profit was at Rs. 2,553.01 crores, which is also increased by 60.55% as compared to an operating profit of Rs. 1,590.2 crores for the quarter ending in June 2020. From a negative EPS of Rs. 10.72 in June 2020, the EPS of Apollo Hospitals Enterprises Ltd has improved and reached Rs. 10.44 per share in June 2021. APOLLOHOSP's stock closed at Rs. 4,746.50 on 20th August’2021 (NSE) and has given a return of 52.78% in the last six months and a return of 179.67% in the previous year.

Read More
Registered Address

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Tel : 91-44-28290956/28293896
Email : investor.relations:apollohospitals.com
Website : http://www.apollohospitals.com
Registrar

Integrated Registry Mgt Servic

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 508869
NSE Code : APOLLOHOSP
Book Closure Date (Month) :
BSE Group : A
ISIN : INE437A01024

FAQ’s on Apollo Hospitals Enterprise Ltd Shares

You can buy Apollo Hospitals Enterprise Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Apollo Hospitals Enterprise Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 03:59 PM the closing price of Apollo Hospitals Enterprise Ltd was Rs.6,453.70.

The latest PE ratio of Apollo Hospitals Enterprise Ltd as of Jul 16, 2024 03:59 PM is 103.43

The latest PB ratio of Apollo Hospitals Enterprise Ltd as of Jul 16, 2024 03:59 PM is 0.07

The 52-week high of Apollo Hospitals Enterprise Ltd share price is Rs. 6,874.45 while the 52-week low is Rs. 4,726.00

According to analyst recommendations, Apollo Hospitals Enterprise Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 03:59 PM, the market cap of Apollo Hospitals Enterprise Ltd stood at Rs. 92,794.53 Cr.

Download App

Download Our App

Play Store App Store
market app